Research member Dr. Bertrand Routy, postdoctoral student Meriem Messaoudene and their team have published a study in the journal Cancer Discovery showing the anti-cancer benefits of the Brazilian camu-camu berry. Castalagin, a molecule from the Amazonian fruit, increases the effectiveness of immunotherapy by altering the microbiome.
The results of this study will allow clinical trials to begin. Castalagin will be used as an adjunct to drugs in certain cancer patients.
Register for the Pancreatic Cancer Conference
22 April 2022
New this year, the Institute is launching registration for the conference, Pancreatic Cancer: Hopes for Treatment. Initiated by research members […]
THE INSTITUTE’S SCIENTIFIC DAY: 30 years of innovation, excellence, success and succession!
12 January 2021
For 30 years now, hundreds of students have passed through the Institute and left their mark there, an essential contribution […]